|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-5-28
|
|
pubmed:abstractText |
Essential fatty acid supplementation has been found to ameliorate certain chronic inflammatory diseases. This effect is thought to be mediated through the modulation of eicosanoid synthesis. Pro-inflammatory eicosanoids have been implicated in ulcerative colitis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1131-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12030955-Administration, Oral,
pubmed-meshheading:12030955-Adolescent,
pubmed-meshheading:12030955-Adult,
pubmed-meshheading:12030955-Aged,
pubmed-meshheading:12030955-Chronic Disease,
pubmed-meshheading:12030955-Colitis, Ulcerative,
pubmed-meshheading:12030955-Dietary Supplements,
pubmed-meshheading:12030955-Double-Blind Method,
pubmed-meshheading:12030955-Fatty Acids, Essential,
pubmed-meshheading:12030955-Female,
pubmed-meshheading:12030955-Humans,
pubmed-meshheading:12030955-Male,
pubmed-meshheading:12030955-Middle Aged,
pubmed-meshheading:12030955-Placebos,
pubmed-meshheading:12030955-Recurrence,
pubmed-meshheading:12030955-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis.
|
|
pubmed:affiliation |
Department of Gastroenterology, Box 201A, Addenbrooke's NHS Trust, Cambridge CB2 2OQ, UK. stephen.middleton@addenbrookes.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
